A Glimpse Into The Expert Outlook On Moderna Through 5 Analysts
A Glimpse Into The Expert Outlook On Moderna Through 5 Analysts
通过5位分析师一窥Moderna的专家展望
In the last three months, 5 analysts have published ratings on Moderna (NASDAQ:MRNA), offering a diverse range of perspectives from bullish to bearish.
在过去的三个月中，有5位分析师公布了对Moderna（纳斯达克股票代码：MRNA）的评级，提供了从看涨到看跌的不同视角。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表简要概述了分析师最近的评级，提供了对过去30天情绪变化的见解，并与前几个月进行了比较以获得整体视角。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $113.8, a high estimate of $142.00, and a low estimate of $86.00. Observing a 44.97% increase, the current average has risen from the previous average price target of $78.50.
分析师通过对12个月目标股价的评估提供了更深入的见解，显示平均目标价为113.8美元，最高估计为142.00美元，低估值为86.00美元。目前的平均价格上涨了44.97％，已从之前的平均目标股价78.50美元上涨。
Understanding Analyst Ratings: A...
了解分析...
登录免费看全文
登录/注册